Hang Lung Achieves Sustainability Milestone: 80% of Mainland Portfolio Powered by Renewable Energy
Forum 66, Palace 66, and Olympia 66 are the first commercial developments in Liaoning Province to be powered by wind and solar energy
HONG KONG SAR & SHANGHAI, CHINA - Media OutReach Newswire - 27 May 2025 - Hang Lung Properties Limited (SEHK stock code: 00101) (the 'Company' or 'Hang Lung') announced that the Company has increased its portfolio of renewable energy-powered properties in mainland China from 50% to 80% of its operating properties. The three additional properties—Forum 66 and Palace 66 in Shenyang, and Olympia 66 in Dalian—have transitioned to renewable energy sources since May 1, 2025, and are the first commercial developments in Liaoning Province to achieve this milestone.
Forum 66, Palace 66, and Olympia 66 are the first commercial developments in Liaoning Province to adopt green energy
'This transaction marks a major step towards realizing Hang Lung's 2050 net zero goal . With these latest pioneering renewable energy projects in mainland China, we are proud to continue leading this journey,' said Mr. Adriel Chan, Chair of Hang Lung Properties and Chair of the Sustainability Steering Committee. 'We will continue to pioneer renewable energy initiatives, support the sustainability targets of our partners, and inspire others to accelerate their decarbonization efforts in line with China's dual carbon ambitions.'
The three properties have secured renewable energy from wind and solar sources through power purchase agreements aligned with China's green energy policy framework. By the end of 2025, Hang Lung is expected to purchase a total of approximately 320 million kWh of renewable energy across eight properties. This achievement surpasses the Company's sustainability target of 25% renewable energy for its mainland China portfolio in 2025. Hang Lung's clear demand signal for renewable energy in multiple cities is helping to accelerate the energy transition, empower tenants to advance their own sustainability commitments with direct access to renewable energy, and foster a greener retail and commercial ecosystem in China.
At Forum 66 in Shenyang, the Green Power Purchase Agreement was signed by (from left) Mr. Arthur Wong, Deputy General Manager – Mainland Business Operation of Hang Lung Properties, Mr. John Haffner, Deputy Director – Sustainability of Hang Lung Properties, Mr. Jinzeng Yu, Deputy General Manager of Northeast Region of China Resources Power, and Ms. Airong Yang, General Manager of China Resources (Liaoning) Electric Power Sales Co., Ltd
'As a leading luxury hotel, we work to ingrain sustainability in all aspects of our operations,' said Mr. Erich Kaiserseder, General Manager, Conrad Shenyang. 'It is great news for us and for our guests that Hang Lung has procured renewable energy for its Liaoning properties, including all the electricity for our hotel in Forum 66.'
'Tenants and landlords need to work together to advance common sustainability goals,' said Ms. Xuan Liu, Director, Dacheng Shenyang Law Firm. 'We are very happy that our office space at Forum 66 is now powered by green electricity thanks to Hang Lung's initiative in the market.'
Located in Shenyang, capital of Liaoning Province, Forum 66 is a mixed-use development comprising a world-class shopping mall, Grade A office tower and the 5-star Conrad Shenyang on Qingnian Da Jie, also known as the 'Golden Corridor', while Palace 66 caters to young and trendy consumers as an aspirational retail and lifestyle destination. Olympia 66 in Dalian is the epicentre of luxury retail and lifestyle destination.
Appendix:
Hang Lung's Renewable Energy Chronology: December 2021: Spring City 66 in Kunming is Hang Lung's first property and the first commercial complex in Yunnan Province to be powered by renewable energy.
January 2023: Parc 66 in Jinan is the first commercial property in Jinan and Shandong Province to be powered by renewable energy.
April 2024: Plaza 66 and Grand Gateway 66 in Shanghai, and Center 66 in Wuxi build on the successes in Kunming and Jinan and are also powered by renewable energy.
May 2025: Forum 66 and Palace 66 in Shenyang, as well as Olympia 66 in Dalian, are the first commercial complexes in Liaoning Province to be powered by renewable energy. Altogether, eight out of ten of Hang Lung's Mainland operating properties are now powered by renewable energy.*
*Green power terms under power purchase agreements for the entire property (covering both landlord and tenant consumption) since May 1, 2025.
Property
Minimum Green Electricity Under Bundled Power Purchase Agreement
Maximum Unbundled Green Electricity Certificate
Spring City 66, Kunming
100%
0%
Parc 66, Jinan
100%
0%
Center 66, Wuxi
98%
2%
Grand Gateway 66, Shanghai
95%
5%
Plaza 66, Shanghai
95%
5%
Forum 66, Shenyang
95%
5%
Palace 66, Shenyang
95%
5%
Olympia 66, Dalian
95%
5%
Hashtag: #HangLung #Forum66 #Palace66 #Olympia66
The issuer is solely responsible for the content of this announcement.
About Hang Lung Properties
www.hanglung.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Global's Top Penny Stocks To Watch In June 2025
Global markets have been navigating a complex landscape, with U.S. stocks showing resilience amid trade policy uncertainties and inflation easing to its slowest pace in four years. Against this backdrop, investors might find opportunities in penny stocks—an investment area that, despite its somewhat outdated name, remains relevant for those seeking growth potential in smaller or newer companies. These stocks can offer surprising value when backed by strong financial health, presenting a mix of value and growth that larger firms might overlook. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$71.94M ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$725.59M ★★★★★★ Foresight Group Holdings (LSE:FSG) £3.96 £445.67M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$453.46M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$716.16M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.15B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,587 stocks from our Global Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shenzhen Asia Link Technology Development Co., Ltd. operates in the technology sector with a market capitalization of CN¥1.66 billion. Operations: No specific revenue segments have been reported for this company. Market Cap: CN¥1.66B Shenzhen Asia Link Technology Development Co., Ltd. is navigating the penny stock landscape with a market cap of CN¥1.66 billion, demonstrating resilience through its substantial cash runway exceeding three years at current free cash flow levels. Despite being unprofitable with negative return on equity, it has reduced losses by 24.7% annually over five years and boasts a seasoned management team and board of directors. Recent earnings reveal improved financial performance, with Q1 2025 revenues rising to CN¥104.95 million from CN¥83.29 million year-over-year, indicating potential growth amidst existing short-term liabilities challenges and stable debt levels relative to assets. Unlock comprehensive insights into our analysis of Shenzhen Asia Link Technology DevelopmentLtd stock in this financial health report. Gain insights into Shenzhen Asia Link Technology DevelopmentLtd's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Guizhou Bailing Group Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development, production, and sale of traditional Chinese medicine products, with a market cap of CN¥5.65 billion. Operations: No specific revenue segments have been reported for the company. Market Cap: CN¥5.65B Guizhou Bailing Group Pharmaceutical Co., Ltd. is navigating financial challenges with a market cap of CN¥5.65 billion, having recently turned profitable despite a significant earnings decline over five years. The company reported Q1 2025 revenues of CN¥760.59 million, down from the previous year, and net income of CN¥24.17 million. Its debt management shows improvement with a reduced debt-to-equity ratio and satisfactory net debt levels supported by operating cash flow covering 23% of its debt. However, short-term liabilities match short-term assets, posing liquidity concerns amidst stable weekly volatility and experienced management oversight. Jump into the full analysis health report here for a deeper understanding of Guizhou Bailing Group Pharmaceutical. Examine Guizhou Bailing Group Pharmaceutical's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Hainan RuiZe New Building Material Co., Ltd operates in China, focusing on the production and sale of commercial concrete and municipal sanitation services, with a market cap of CN¥3.98 billion. Operations: The company generates revenue primarily from its operations in China, amounting to CN¥1.23 billion. Market Cap: CN¥3.98B Hainan RuiZe New Building Material Co., Ltd, with a market cap of CN¥3.98 billion, faces financial challenges as it remains unprofitable with increasing losses over the past five years. Despite reporting sales of CN¥1.28 billion for 2024, revenue declined from the previous year, and net losses persisted at CN¥241.53 million. The company's high net debt to equity ratio of 175.8% raises concerns about its financial leverage, although it maintains a stable cash runway due to positive free cash flow growth. Additionally, short-term assets exceed both short and long-term liabilities, providing some balance sheet strength amidst volatility stability. Navigate through the intricacies of Hainan RuiZe New Building MaterialLtd with our comprehensive balance sheet health report here. Learn about Hainan RuiZe New Building MaterialLtd's historical performance here. Take a closer look at our Global Penny Stocks list of 5,587 companies by clicking here. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:002316 SZSE:002424 and SZSE:002596. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
3 Asian Penny Stocks With Market Caps Below US$800M
As Asian markets navigate the complexities of global trade tensions and economic shifts, investors are increasingly looking for opportunities beyond the major indices. Penny stocks, a term that may seem outdated but remains significant, refer to smaller or newer companies that can offer unique investment opportunities. In this article, we explore three such penny stocks in Asia that stand out for their financial strength and potential for growth, providing investors with a chance to uncover hidden value in lesser-known companies. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.88 HK$3.25B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.09 HK$1.74B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ Halcyon Technology (SET:HTECH) THB2.66 THB798M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.176 SGD35.06M ★★★★★★ BRC Asia (SGX:BEC) SGD3.11 SGD853.23M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.38 HK$50.15B ★★★★★★ Click here to see the full list of 1,153 stocks from our Asian Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Scales Corporation Limited is involved in the manufacturing and trading of food ingredients across New Zealand, Asia, Europe, North America, and other international markets, with a market cap of NZ$648.15 million. Operations: The company generates revenue from three main segments: Horticulture (NZ$248.88 million), Global Proteins (NZ$266.79 million), and Logistics (NZ$98.80 million). Market Cap: NZ$648.15M Scales Corporation Limited, with a market cap of NZ$648.15 million, demonstrates strong financial health as its short-term assets cover both short-term and long-term liabilities. The company has achieved significant earnings growth of 486.9% over the past year, surpassing industry averages and improving its net profit margins from 0.9% to 5.3%. Despite this growth, it trades at a substantial discount to its estimated fair value, suggesting potential for appreciation. Debt management is robust with cash flow well covering debt obligations and interest payments comfortably managed by EBIT. Management's experience further supports operational stability without recent shareholder dilution concerns. Click here and access our complete financial health analysis report to understand the dynamics of Scales. Gain insights into Scales' future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Tian Ge Interactive Holdings Limited operates live social video platforms and other services in China and internationally, with a market cap of HK$773.88 million. Operations: The company's revenue primarily comes from its Online Interactive Entertainment segment, which generated CN¥5.64 million. Market Cap: HK$773.88M Tian Ge Interactive Holdings has transitioned to profitability, reporting a net income of CN¥20 million for 2024 compared to a significant loss the previous year. Despite low revenue of CN¥10.16 million, the company's financial performance improved due to increased fair value of financial assets and unlisted equity investments. However, its dividend yield is not well-supported by earnings or cash flow. The company maintains more cash than debt but struggles with negative operating cash flow impacting debt coverage. Recent board changes indicate strategic shifts, with experienced management potentially enhancing governance and operational synergies in the future. Take a closer look at Tian Ge Interactive Holdings' potential here in our financial health report. Explore historical data to track Tian Ge Interactive Holdings' performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Travel International Investment Hong Kong Limited offers travel and tourism services, with a market capitalization of HK$5.92 billion. Operations: The company's revenue is primarily derived from Tourist Attraction and Related Operations at HK$2.35 billion, Passenger Transportation Operations at HK$1.09 billion, Hotel Operations at HK$820.65 million, and Travel Document and Related Operations at HK$344.02 million. Market Cap: HK$5.92B China Travel International Investment Hong Kong Limited, with a market cap of HK$5.92 billion, primarily generates revenue from tourist attractions and transportation services. Despite having more cash than debt and stable short-term liabilities coverage, the company faces challenges with declining profit margins, which fell to 2.3% from 5.3% last year due to a large one-off loss of HK$223.5 million in 2024. Recent amendments to its Articles of Association aim to modernize operations and improve flexibility in corporate governance, while experienced management oversees strategic adjustments amid negative earnings growth over the past year. Click to explore a detailed breakdown of our findings in China Travel International Investment Hong Kong's financial health report. Assess China Travel International Investment Hong Kong's future earnings estimates with our detailed growth reports. Click through to start exploring the rest of the 1,150 Asian Penny Stocks now. Ready To Venture Into Other Investment Styles? We've found 20 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NZSE:SCL SEHK:1980 and SEHK:308. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
Asian Growth Stocks With High Insider Ownership And 29% ROE
As global markets navigate the complexities of trade policies and inflation concerns, Asia remains a focal point for investors seeking growth opportunities. In this context, growth companies with high insider ownership can offer unique insights into potential value creation, particularly when they demonstrate strong financial metrics such as a 29% return on equity (ROE). Name Insider Ownership Earnings Growth Vuno (KOSDAQ:A338220) 15.6% 109.8% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Shanghai Huace Navigation Technology (SZSE:300627) 24.5% 23.4% Schooinc (TSE:264A) 30.6% 68.9% Oscotec (KOSDAQ:A039200) 21.1% 94.4% NEXTIN (KOSDAQ:A348210) 12.4% 33.9% Nanya New Material TechnologyLtd (SHSE:688519) 11% 63.3% M31 Technology (TPEX:6643) 30.8% 63.4% Laopu Gold (SEHK:6181) 35.5% 40.2% Fulin Precision (SZSE:300432) 13.6% 44.2% Click here to see the full list of 617 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Beauty Farm Medical and Health Industry Inc. (SEHK:2373) operates in the medical and health industry with a market capitalization of approximately HK$5.77 billion. Operations: The company's revenue segments include Aesthetic Medical Services at CN¥927.92 million, Subhealth Medical Services at CN¥200.98 million, Beauty and Wellness Services from Direct Stores at CN¥1.31 billion, and Beauty and Wellness Services from Franchisee and Others at CN¥137.56 million. Insider Ownership: 33.9% Return On Equity Forecast: 30% (2027 estimate) Beauty Farm Medical and Health Industry shows potential as a growth company with high insider ownership in Asia. Despite slower than desired revenue growth at 11.6% annually, it surpasses the Hong Kong market average of 8.2%. Earnings are forecast to grow at 18.3% per year, outpacing the market's 10.4%. Recent strategic moves include seeking M&A opportunities to enhance profit margins and synergies, while board changes aim to improve corporate governance and meet gender diversity requirements. Click here and access our complete growth analysis report to understand the dynamics of Beauty Farm Medical and Health Industry. Our valuation report unveils the possibility Beauty Farm Medical and Health Industry's shares may be trading at a premium. Simply Wall St Growth Rating: ★★★★★★ Overview: Nanya New Material Technology Co., Ltd specializes in the manufacturing, design, development, and sale of composite materials with a market cap of CN¥8.91 billion. Operations: Nanya New Material Technology Co., Ltd generates revenue through its core activities of manufacturing, designing, developing, and selling composite materials. Insider Ownership: 11% Return On Equity Forecast: 20% (2028 estimate) Nanya New Material Technology Ltd demonstrates strong growth potential with its earnings forecasted to increase significantly at 63.3% annually, outpacing the Chinese market's 23.4%. Despite a volatile share price recently, the company became profitable this year and reported Q1 revenue of CNY 952.45 million, up from CNY 656.69 million last year. With no substantial insider trading activity in recent months, Nanya's revenue is expected to grow faster than the market average at 22.7% annually. Take a closer look at Nanya New Material TechnologyLtd's potential here in our earnings growth report. Upon reviewing our latest valuation report, Nanya New Material TechnologyLtd's share price might be too optimistic. Simply Wall St Growth Rating: ★★★★★★ Overview: Naruida Technology Co., Ltd. specializes in the manufacturing and sale of polarized multifunctional active phased array radars in China, with a market cap of CN¥15.38 billion. Operations: The company's revenue primarily comes from its Scientific & Technical Instruments segment, amounting to CN¥371.98 million. Insider Ownership: 12.7% Return On Equity Forecast: 20% (2028 estimate) Naruida Technology shows promising growth prospects with its earnings expected to grow significantly at 54.4% annually, surpassing the Chinese market's 23.4%. Revenue is forecasted to increase by 47.7% per year, well above the market average of 12.4%. Recent financial results highlight robust performance, with Q1 revenue reaching CNY 58.19 million and net income rising to CNY 21.67 million from CNY 4.23 million last year, amidst no major insider trading activity recently. Click here to discover the nuances of Naruida Technology with our detailed analytical future growth report. According our valuation report, there's an indication that Naruida Technology's share price might be on the expensive side. Take a closer look at our Fast Growing Asian Companies With High Insider Ownership list of 617 companies by clicking here. Curious About Other Options? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:2373 SHSE:688519 and SHSE:688522. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
